In Vitro Characterization of a Sustained-Release Formulation for Enfuvirtide

被引：10
|
作者：
Rothstein, Sam N. [1 ]
Huber, Kelly D. [2 ]
Siuis-Cremer, Nicolas [2 ]
Little, Steven R. [1 ,3 ,4 ,5 ,6 ]
机构：
[1] Qrono Inc, Pittsburgh, PA USA
[2] Univ Pittsburgh, Dept Med, Div Infect Dis, Pittsburgh, PA USA
[3] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA
[4] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA
[5] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA
[6] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2014年 / 58卷 / 03期
关键词：
ERODING POLYMER MATRICES; PREDICTION; HIV-1; MODEL;
D O I：
10.1128/AAC.02440-13
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Although approved by the U.S. Food and Drug Administration, enfuvirtide is rarely used in combination antiretroviral therapies (cART) to treat HIV-1 infection, primarily because of its intense dosing schedule that requires twice-daily subcutaneous injection. Here, we describe the development of enfuvirtide-loaded, degradable poly(lactic-co-glycolic) acid microparticles that provide linear in vitro release of the drug over an 18-day period. This sustained-release formulation could make enfuvirtide more attractive for use in cART.
引用
收藏
页码：1797 / 1799
页数：3
相关论文
共 50 条
  • [31] FORMULATION AND EVALUATION OF SUSTAINED-RELEASE PARACETAMOL TABLETS
    AHMED, M
    ENEVER, RP
    JOURNAL OF CLINICAL AND HOSPITAL PHARMACY, 1981, 6 (01): : 27 - 38
  • [32] BIOAVAILABILITY OF METOCLOPRAMIDE FROM A SUSTAINED-RELEASE FORMULATION
    BERNER, G
    LEUSCHNER, F
    WAGENER, HH
    BECKER, A
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1984, 34-1 (05): : 637 - 639
  • [33] FORMULATION AND IN-VITRO CHARACTERIZATION OF SUSTAINED RELEASE INDOMETHACIN MICROCAPSULES
    Sharma, Kuchi. Shishir Chandra
    Naresh, Y.
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 1 (01): : 17 - 25
  • [34] Phages in a thermoreversible sustained-release formulation targeting E. faecalis in vitro and in vivo
    Shlezinger, Mor
    Friedman, Michael
    Houri-Haddad, Yael
    Hazan, Ronen
    Beyth, Nurit
    PLOS ONE, 2019, 14 (07):
  • [35] Preparation and in vitro evaluation of gliclazide sustained-release matrix pellets: formulation and storage stability
    Wang, Lin
    Wang, Juan
    Lin, Xia
    Tang, Xing
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2010, 36 (07) : 814 - 822
  • [36] Formulation and In Vitro, In Vivo Evaluation of Effervescent Floating Sustained-Release Imatinib Mesylate Tablet
    Kadivar, Ali
    Kamalidehghan, Behnam
    Javar, Hamid Akbari
    Davoudi, Ehsan Taghizadeh
    Zaharuddin, Nurul Dhania
    Sabeti, Bahareh
    Chung, Lip Yong
    Noordin, Mohamed Ibrahim
    PLOS ONE, 2015, 10 (06):
  • [37] Once-daily sustained-release matrix tablets of nicorandil: Formulation and in vitro evaluation
    K. Raghuram Reddy
    Srinivas Mutalik
    Srinivas Reddy
    AAPS PharmSciTech, 4 (4)
  • [38] FORMULATION, IN-VITRO AND IN-VIVO EVALUATION OF SUSTAINED-RELEASE MEBEVERINE HYDROCHLORIDE MICROSPHERES
    BAYOMI, MA
    KHIDR, SH
    ABDELHADY, SS
    ALANGARY, AA
    PHARMAZEUTISCHE INDUSTRIE, 1994, 56 (02): : 192 - 194
  • [39] SUSTAINED-RELEASE TABLET FORMULATION FOR A NEW IRON CHELATOR
    KAUL, D
    VENKATARAM, S
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1992, 18 (09) : 1023 - 1035
  • [40] SUSTAINED-RELEASE TABLET FORMULATION OF DIETHYLCARBAMAZINE .3.
    BAVEJA, SK
    RAO, KVR
    DEVI, KP
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 27 (2-3) : 157 - 162
12345